08.30.24 -- Bacterial Endotoxin Testing, Part 4: Key Tests For Endotoxin Detection

Explore high voltage leak detection, headspace analysis, and vacuum and pressure decay as applied in pharmaceutical manufacturing.

Learn about innovative software that addresses the need of pharmaceutical manufacturing plants to centralize and trend data from various sources important to environmental monitoring (EM) systems.

Emerging biotechs are behind many of the pharma industry’s latest therapeutic innovations. And while CDMOs are eager to work with them, they must learn to accommodate their unique needs.

Here, we address a number of OHS, regulatory, and process requirements imperative to the delivery of critical containment systems.

Three experts discuss the role and value of collaborations and what strategies can be used to help improve biomanufacturing resilience in an unpredictable but promising future.

Understanding the root cause of a supply chain issue helps set more realistic timelines for customers and generates more collaborative problem-solving efforts between drug manufacturers and suppliers.

Examine how a platform that leverages polymeric implantable drug delivery systems enables improved bioavailability, patient compliance, and mitigation of issues associated with repeated injections.

CMOs and CPOs currently face significant challenges, including strong competition, high cost pressure, and more. Learn why being agile, flexible, and responsive is bound to pay off.

When it comes to fill/finish manufacturing of parenteral liquid pharmaceuticals, your choice of barrier technology is crucial.

The right comparator sourcing strategy is critical. Review what sponsors need to consider when selecting the right provider to source the needed commercial products.

As pharma companies aim to overcome development obstacles, it is important to incorporate GMP expertise alongside novel technologies that can enhance the properties of APIs and dosage forms.

With a growing interest in developing new and improved bioconjugate drugs, explore an “innovation through collaboration” approach that can facilitate access to next-generation conjugation technologies.